医学
芬特明
奥利斯特
利拉鲁肽
减肥
2型糖尿病
肥胖
托吡酯
糖尿病
重症监护医学
安非他酮
体重管理
内科学
内分泌学
戒烟
精神科
病理
癫痫
作者
Kishore M. Gadde,Corby K. Martin,Hans‐Rudolf Berthoud,Steven B. Heymsfield
标识
DOI:10.1016/j.jacc.2017.11.011
摘要
Obesity continues to be among the top health concerns across the globe. Despite our failure to contain the high prevalence of obesity, we now have a better understanding of its pathophysiology, and how excess adiposity leads to type 2 diabetes, hypertension, and cardiovascular disease. Lifestyle modification is recommended as the cornerstone of obesity management, but many patients do not achieve long-lasting benefits due to difficulty with adherence as well as physiological and neurohormonal adaptation of the body in response to weight loss. Fortunately, 5 drug therapies—orlistat, lorcaserin, liraglutide, phentermine/topiramate, and naltrexone/bupropion—are available for long-term weight management. Additionally, several medical devices are available for short-term and long-term use. Bariatric surgery yields substantial and sustained weight loss with resolution of type 2 diabetes, although due to the high cost and a small risk of serious complications, it is generally recommended for patients with severe obesity. Benefit-to-risk balance should guide treatment decisions.
科研通智能强力驱动
Strongly Powered by AbleSci AI